Provided by Tiger Trade Technology Pte. Ltd.

Editas Medicine

3.06
-0.1000-3.16%
Post-market: 3.070.0138+0.45%19:30 EDT
Volume:2.08M
Turnover:6.40M
Market Cap:468.18M
PE:-4.19
High:3.14
Open:3.12
Low:3.03
Close:3.16
52wk High:4.54
52wk Low:1.66
Shares:153.00M
Float Shares:115.00M
Volume Ratio:0.68
T/O Rate:1.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7307
EPS(LYR):-1.8036
ROE:-118.82%
ROA:-23.29%
PB:4.45
PE(LYR):-1.70

Loading ...

Editas Medicine Files $400 Million Mixed Shelf

MT Newswires Live
·
2 hours ago

Editas Medicine files $400M mixed securities shelf

TIPRANKS
·
3 hours ago

Editas Medicine - May Offer up to $400 Mln of Securities - SEC Filing

THOMSON REUTERS
·
3 hours ago

Acrivon Therapeutics Names Michaela Levin Chief Business Officer

Reuters
·
Yesterday

Editas Medicine Initiated at Buy by Ladenburg Thalmann

Dow Jones
·
Aug 18

Ladenburg Thalmann Initiates Editas Medicine at Buy With $6 Price Target

MT Newswires Live
·
Aug 18

Editas Medicine, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 10

Editas Medicine Director Ellinor Patrick Thomas II Files Initial Beneficial Ownership Statement

Reuters
·
Aug 08

Editas Medicine, Inc. Expected to Post a Loss of 27 Cents a Share - Earnings Preview

Reuters
·
Aug 07

Intellia Therapeutics Q2 Collaboration Revenue Falls, Net Loss Widens

Reuters
·
Aug 06

Analysts Are Bullish on Top Healthcare Stocks: MannKind (MNKD), Disc Medicine (IRON)

TIPRANKS
·
Aug 06

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ginkgo Bioworks Holdings (DNA), Exelixis (EXEL) and Editas Medicine (EDIT)

TIPRANKS
·
Aug 06

Editas Medicine Q2 2026 earnings: Deferred revenue and restructuring narrow the loss

TradingKey
·
Aug 06

Editas Medicine Strengthens Board With New Cardiology Director

TIPRANKS
·
Aug 06

Editas Medicine Q2 EPS $(0.15) Beats $(0.27) Estimate, Sales $11.900M Beat $2.800M Estimate

Benzinga Earnings
·
Aug 06

Editas Medicine Q2 Net Loss Narrows and Beats Estimates

Reuters
·
Aug 06

Editas Medicine Q2 Net Income USD -18.23 Million Vs. IBES Estimate USD -27 Million

Reuters
·
Aug 06

Editas Medicine Announces Second Quarter 2026 Results and Business Updates

THOMSON REUTERS
·
Aug 06

Editas Medicine Q2 Basic EPS USD -0.15

THOMSON REUTERS
·
Aug 06

Editas Medicine Names Patrick Ellinor to Board, Elliott Levy to Step Down

Reuters
·
Aug 05